| JXHB2400010 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-01-05 | | Lilly Del Caribe Inc;Loxo Oncology Inc | | | view |
| JXHB2400008 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-01-05 | | Eli Lilly & Company;Lilly Del Caribe Inc | | | view |
| JXHB2400009 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-01-05 | | Lilly Del Caribe Inc;Loxo Oncology Inc | | | view |
| JXHB2400007 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-01-05 | | Eli Lilly & Company;Lilly Del Caribe Inc | | | view |
| JXHL2101282 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-12-24 | | Loxo Oncology Inc;Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| JXHL2101283 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-12-24 | | Loxo Oncology Inc;Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| JXHL2101284 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-12-24 | | Loxo Oncology Inc;Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| JXHL2101137 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-07-16 | | Loxo Oncology Inc;Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| JXHL2101138 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-07-16 | | Loxo Oncology Inc;Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| JXHL2101139 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-07-16 | | Loxo Oncology Inc;Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| JXHB2101023 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2021-06-21 | | Lilly Del Caribe Inc;Loxo Oncology Inc | | | view |
| JXHB2101024 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2021-06-21 | | Eli Lilly & Company;Lilly Del Caribe Inc | | | view |
| JXHL2100114 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
| JXHL2100115 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
| JXHL2100113 | LOXO-305片 | pirtobrutinib | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-04-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-04-07 | view |
| JXHL2100090 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXHL2100093 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXHL2100092 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXHL2100091 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2021-03-20 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Loxo Oncology Inc | In Review | 2021-03-19 | view |
| JXHB2100004 | LOXO-305 | pirtobrutinib | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2021-01-08 | 礼来苏州制药有限公司 | Lilly Suzhou Pharmaceutical Co Ltd;Eli Lilly & Company;Lilly Del Caribe Inc | In Review | 2021-01-07 | view |
